Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net loss $ (4,323,555) $ (5,454,256)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation 570,385 675,966
Accretion of notes payable discount 84,101
Loss on extinguishment of debt 2,072,365
Loss on disposition of assets 1,281
Gain of equity method investment (2,507)
Depreciation and amortization 37,634 33,228
Changes in assets and liabilities:    
Increase (decrease) in deferred income (29,088) 196,936
Decrease in prepaid and other assets 694,036 114,279
Increase (decrease) in accounts payable and accrued expenses (66,306) 57,135
Net cash used in operating activities (3,119,401) (2,218,965)
Cash flows from investing activities:    
Purchase of property and equipment (2,500) (90,958)
Investment in joint venture (135,000)
Net cash used by investing activities (137,500) (90,958)
Cash flows from financing activities:    
Proceeds from the sale of equity 30,000 7,071,192
Proceeds from the issuance of debt 2,000,000
Payment of deferred debt acquisition costs (130,988)
Principal payments on debt (related party) (41,500)
Payment of deferred offering costs (1,093,268)
Net cash provided by financing activities 1,899,012 5,936,424
Net increase (decrease) in cash (1,357,889) 3,626,501
Cash and cash equivalents beginning of period 3,534,454 998,737
Cash and cash equivalents end of period 2,176,565 4,625,238
Supplemental disclosure of cash flow information:    
Interest paid 26,000 73,523
Schedule of non-cash investing and financing activities:    
Warrants issued for services $ 256,198